Summary
The cellular electrophysiological effects of restacorin, a new antiarrhythmic agent were studied using conventional microelectrode techniques in isolated dog cardiac Purkinje fibres. Restacorin (1 – 30 µmol/l) decreased the maximum rate of rise of the action potential upstroke and action potential amplitude while action potential duration measured at 90% of repolarization was shortened in a concentration-dependent manner during pacing at a constant basic cycle length of 500 ms. The effect of 10 µmol/l restacorin on maximal rate of rise of the action potential upstroke and on action potential duration measured at 90% of repolarization were also studied while varying the constant pacing cycle length between 300 and 5000 ms. The results of these studies indicated a rate-dependent effect of restacorin on the action potential characteristics examined. After abrupt changes in cycle length, 10 µmol/l restacorin slowed the fast component of the relation for restitution of action potential duration from 155.3 ± 5.2 ms (control, n = 6) to 217.1 ± 17.8 ms (n = 6, P < 0.05). In the presence of restacorin (10 µmol/l), a second slow component for recovery of maximal action potential up stroke rising velocity was expressed having a time constants of 8.5 ± 1.2 s. The range of premature action potential durations was significantly decreased (by 57.1%, P < 0.01) by 10 µmol/l restacorin. These results indicate that the cellular electrophysiological effects produced by restacorin in dog cardiac Purkinje fibres best resemble those produced by recognized class Ic antiarrhythmic drugs.
Similar content being viewed by others
References
Arita M, Goto M, Nagamoto Y, Saikawa T (1979) Electrophysiological actions of mexiletine (Kö 1173) on canine Purkinje fibers and ventricular muscle. Br J Pharmacol 67:143–152
Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C (1979) The steady state TTX-sensitive (“window”) sodium current in cardiac Purkinje fibres. Pflügers Arch 379:137–142
Bigger JT, Mandel WJ (1970) Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers. J Clin Invest 49:62–77
Campbell TJ (1983) Resting and rate-dependent depression of maximum rate of depolarization (\(\dot V\) max) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide. J Cardiovasc Pharmacol 5:291–296
Chen C-M, Gettes LS, Katzung BG (1975) Effects of lidocaine and quinidine on the steady state characteristics and recovery kinetics (dV/dt)max in guinea pig ventricular myocardium. Circ Res 37:20–29
Cohen CJ, Bean BP, Tsien RW (1984) Maximal upstroke velocity as an index of available sodium conductance. Circ Res 54:636–651
Courtney K (1980) Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J Mol Cell Cardiol 12:1273–1286
DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102
Elharrar V (1988) Recovery from use-dependent block of \(\dot V\) max and restitution of action potential duration in canine cardiac Purkinje fibers. J Pharmacol Exp Ther 246:235–242
Elharrar V, Surawicz B (1983) Cycle length effect on restitution of action potential duration in dog cardiac fibers. Am J Physiol 244:H782-H792
Gibson JK, Somani P, Bassett AL (1978) Electrophysiologic effects of encainide (MJ 9067) on canine Purkinje fibers. Eur J Pharmacol 52:161–169
Heistracher P (1971) Mechanism of action of antifibrillatory Drugs. Naunyn-Schmiedeberg's Arch Pharmacol 269:199–212
Hiraoka M, Kawano S (1987) Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J Physiol (Lond) 410:187–212
Hoffman BF, Rosen MR (1981) Cellular mechanisms for cardiac arrhythmias. Circ Res 49:1–15
Hohnloser S, Weirich J, Antoni H (1982) Effects of mexiletine on steady-state characteristics and recovery kinetics of \(\dot V\) max and conduction velocity in guinea pig myocardium. J Cardiovasc Pharmacol 4:232–239
Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann Rev Pharmacol Toxicol 24:387–423
Ikeda N, Singh BN, Davis LD, Hauswirth O (1985) Effects of flecainide on the electrophysiological propeties of isolated canine and rabbit myocardial fibers. J Am Coll Cardiol 5:303–310
Imaizumi Y, Giles WR (1987) Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Physiol 253:H704-H708
Johnson EA, McKinnon MG (1957) The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation. J Pharmacol Exp Ther 120:460–468
Kodama I, Morimoto M, Toyama J, Shibata S (1989) Electrophysiologic effects of TYB-2823, a new antiarrhytmic agent on isolated guinea pig ventricular muscles. J Cardiovasc Pharmacol 13:616–623
Kohlhardt M, Seifert C (1985) Properties of \(\dot V\) max block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle. Naunyn-Schmiedeberg's Arch Pharmacol 330:235–244
Kuo C-S, Amlie JP, Munakata K, Reddy CP, Surawicz B (1983a) Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res 17:152–161
Kuo C-S, Amlie JP, Munakata K, Reddy CP, Surawicz B (1983b) Characteristics and possible mechanism of ventricular arrhyth mia dependent on the dispersion of action potential durations. Circulation 67:1356–1367
Kurthy M, Rabloczky G, Varró A, Szatmary LJ, Jaszlits L, Wellmann J, Erczy I (1985) New antiarrhythmic agent with positive cardiac actions (GYKI-38 233). In: Szekeres L and Papp JGY (eds) Advances in Pharmacological Research and Practice, Proceedings of the 4th Congress of the Hungarian Pharmacological Society, Budapest 1985, Vol 1. Pergamon Oxford, Akademiai Kiado Budapest, pp. 221–215
Kus T, Sasyniuk BI (1978) The electrophysiological effects of disopyramide on canine ventricular muscle and Purkinje fibers in normal and low potassium. Can J Physiol Pharmacol 56:139–149
Lathrop DA, Varró A, Schwartz A (1989) Rate-dependent electrophysiological effects of OPC-8212: comparison to sotalol. Eur J Pharmacol 164:487–496
Nattel S, Zeng F-D (1984) Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers. J Pharmacol Exp Ther 229:283–291
Ohmura T, Hayashi H, Muramatsu I (1988) Antiarrhythmic and hemodynamic effect of a new antiarrhythmic drug, TYB-3823, in dogs and rats. Jpn J Pharmacol 46:211
Rabloczky G, Varró A, Kurthy M, Bodi I, Jednakovits A, Szathmary L, Jaszlits L, Kiraly I (1988) Pharmacology of BGYKI-38 233, a new antiarrhythmic agent. Pharmacol Res Commun 20:Suppl I 71–72
Rosen MR, Merker C, Gelband H, Hoffman BF (1973) Effects of procaine amide on the electrophysiological properties of the canine ventricular conducting system. J Pharmacol Exp Ther 185:438–446
Sada H, Kohima M, Bant T (1979) Effects of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Naunyn-Schmiedeberg's Arch Pharmacol 309:179–190
Sada H, Kojima M, Ban T (1980) Effects of tocainide and lidocaine in the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 314:67–82
Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anaesthetics. Biophys J 46:15–27
Tritthart H, Fleckenstein B, Fleckenstein A (1971) Some fundamental actions of antiarrhythmic drugs on the excitability and contractility of single myocardial fibers. Naunyn-Schmiedeberg's Arch Pharmacol 269:212–219
Varró A, Elharrar V, Surawicz B (1985a) Frequency-dependent effects of several class I antiarrhythmic drugs on (\(\dot V\) max) of action potential upstroke in canine cardiac Purkinje fibers. J Cardiovasc Pharmacol 7:482–492
Varró A, Elharrar V, Surawicz B (1985b) Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers. J Pharmacol Exp Ther 233:304–311
Varró A, Nakaya Y, Elharrar V, Surawicz B (1986) Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol 8:178–185
Wang CM, Parker CH (1980) Reassessment of electrophysiological effects of the antiarrhythmic agent quinidine in canine Purkinje fibers. Life Sci 27:663–670
West TC, Amory DW (1960) Single fiber recording of the effects of quinidine at atrial and pacemaker sites in the isolated right atrium of the rabbit. J Pharmacol Exp Ther 130:183–193
Zipes DP (1988) Management of cardiac arrhythmias: Pharmacological, electrical and surgical techniques. In: Braunwald E (ed) Heart disease: A textbook of cardiovascular medicine. Saunders, Philadelphia, pp 621–657
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Varrò, A., Knilans, T.K., Nànàsi, P.P. et al. Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine purkinje fibres. Naunyn-Schmiedeberg's Arch Pharmacol 342, 691–697 (1990). https://doi.org/10.1007/BF00175714
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175714